Sheaff Brock Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $415K | Buy |
835
+149
| +22% | +$74.1K | 0.04% | 288 |
|
2024
Q4 | $357K | Hold |
686
| – | – | 0.03% | 306 |
|
2024
Q3 | $424K | Hold |
686
| – | – | 0.04% | 274 |
|
2024
Q2 | $379K | Sell |
686
-8
| -1% | -$4.42K | 0.04% | 288 |
|
2024
Q1 | $403K | Hold |
694
| – | – | 0.03% | 308 |
|
2023
Q4 | $368K | Hold |
694
| – | – | 0.03% | 309 |
|
2023
Q3 | $351K | Hold |
694
| – | – | 0.03% | 296 |
|
2023
Q2 | $362K | Sell |
694
-14
| -2% | -$7.31K | 0.03% | 304 |
|
2023
Q1 | $408K | Hold |
708
| – | – | 0.04% | 287 |
|
2022
Q4 | $390K | Buy |
708
+29
| +4% | +$16K | 0.04% | 283 |
|
2022
Q3 | $344K | Buy |
679
+4
| +0.6% | +$2.03K | 0.04% | 295 |
|
2022
Q2 | $367K | Hold |
675
| – | – | 0.03% | 288 |
|
2022
Q1 | $399K | Sell |
675
-154
| -19% | -$91K | 0.03% | 308 |
|
2021
Q4 | $554K | Buy |
829
+100
| +14% | +$66.8K | 0.04% | 260 |
|
2021
Q3 | $417K | Hold |
729
| – | – | 0.03% | 298 |
|
2021
Q2 | $368K | Sell |
729
-2,120
| -74% | -$1.07M | 0.03% | 320 |
|
2021
Q1 | $1.3M | Buy |
2,849
+12
| +0.4% | +$5.48K | 0.1% | 128 |
|
2020
Q4 | $1.32M | Buy |
2,837
+2,078
| +274% | +$968K | 0.11% | 117 |
|
2020
Q3 | $335K | Sell |
759
-70
| -8% | -$30.9K | 0.03% | 276 |
|
2020
Q2 | $300K | Hold |
829
| – | – | 0.03% | 296 |
|
2020
Q1 | $235K | Buy |
829
+150
| +22% | +$42.5K | 0.03% | 299 |
|
2019
Q4 | $221K | Buy |
+679
| New | +$221K | 0.02% | 385 |
|